Skip to main content
. 2003 Oct;71(10):5461–5471. doi: 10.1128/IAI.71.10.5461-5471.2003

TABLE 1.

Bacterial strains and plasmids used in this study

Strain or plasmid Descriptiona Source or reference
Strains
    V. vulnificus
        MO6-24/O Clinical isolate 47
        CMCP6 Clinical isolate Chonnam National University Hospital
        CMCP98K Clinical isolate Chonnam National University Hospital
        CMM1701 CMCP6 with the insertion mutation in Vv-ive-1 gene; Cmr This study
        CMM1702 CMCP6 with the insertion mutation in Vv-ive-2 gene; Cmr This study
        CMM1703 CMCP6 with the insertion mutation in Vv-ive-3 gene; Cmr This study
        CMM1704 MO6-24/O with the insertion mutation in Vv-ive-4 gene; Cmr This study
        CMM1705 CMCP6 with the insertion mutation in Vv-ive-5 gene; Cmr This study
        CMM1706 CMCP6 with the insertion mutation in Vv-ive-6 gene; Cmr This study
        CMM1707 CMCP6 with the deletion mutation in Vv-ive-7 gene This study
        CMM1708 MO6-24/O with the deletion mutation in Vv-ive-8 gene This study
        CMM1709 MO6-24/O with the insertion mutation in Vv-ive-9 gene; Cmr This study
        CMM1710 CMCP6 with the deletion mutation in Vv-ive-10 gene This study
        CMM1711 CMCP6 with the insertion mutation in Vv-ive-11 gene; Cmr This study
        CMM1712 CMCP6 with the insertion mutation in Vv-ive-12 gene; Cmr This study
        CMM1715 CMM1710 containing pCMM1701; Ampr Tcr This study
    E. coli
        BL21(DE3) FompT hsdSB(rB mB) gal dcm (DE3) Novagen
        DH5α F φ80dlacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK mK+) phoA supE44 λthi-1 gyrA96 relA1 Laboratory collection
        SY327 λpir Δ(lac pro) argE(Am) rif nalA recA56 λpir lysogen 39
        SM10 λpir thi thr leu tonA lacY supE recA::RP4-2-Tcr::Mu λpirR6K lysogen; Kmr 39
Plasmids
    pET30a,b,c Inducible-expression vectors carrying N-terminal His · Tag/thrombin/S · Tag/enterokinase configuration, providing three different reading frames at the multicloning site; Kmr Novagen
    pDM4 A suicide vector with ori R6K sacB, Cmr 40
    pLAFR3 IncP cosmid vector; Tcr 54
    pLAFR3II pLAFR3 with bla inserted at the cos site This study
    pRK2013 IncP Kmr Tra Rk2+repRK2 repE1 9
    pCMM1701 pLAFR3I1 with hlyU ORF This study
    pUTKm1 Tn5-based insertion delivery plasmid; Ampr 23
a

Cmr, CHL resistance; Tcr, TET-resistance; Kmr, KAN resistance; Ampr, AMP resistance.

HHS Vulnerability Disclosure